Scienmag

SEPTEMBER 20, 2020

A study of approximately 200,000 blood samples from the UK Biobank has identified more than 2,000 undiagnosed cases of type 2 diabetes.

Biobanking 47

Biobanking Medicine 47

Scienmag

NOVEMBER 12, 2020

In a study that has unprecedented implications to advance both medicine and biodiversity conservation, researchers have sequenced 131 new placental mammal genomes, bringing the worldwide total to more than 250 In a study that has unprecedented implications to advance both medicine and biodiversity conservation, researchers have sequenced 131 new placental (..)

Biobanking 41

Biobanking Medicine Genome Genomics 41

JAMA Internal Medicine

SEPTEMBER 12, 2022

This population-based prospective cohort study using UK Biobank data for 78 500 individuals with 7 years of follow-up examines associations of daily step counts and intensity with all-cause mortality and cancer and cardiovascular disease-related morbidity and mortality.

Biobanking 93

Biobanking 93

Drug Discovery World

MARCH 7, 2023

Qatar’s pharmaceutical and healthcare markets, whilst receiving significant government attention, are still within their beginnings.

Biobanking 52

Biobanking Drugs Genome Genomics 52

Scienmag

JULY 4, 2021

Credit: Unsplash A state-of-the-art genetic biobank could hold the key to preventing Sudden Infant Death Syndrome (SIDS), potentially saving the lives of hundreds of babies who die from the devastating condition each year.

Genetics 61

Genetics Biobanking DNA Development 61

The Pharma Data

MARCH 1, 2022

to build a scalable data, analytics, and infrastructure platform This collaboration aims at capturing translational disease insights from large external healthcare biobanks and maximizing value of data for drug discovery and precision medicine. Boehringer Ingelheim partners with Lifebit Biotech, Ltd.

Biobanking 52

Biobanking Genome Genomics Genome Project 52

BioTech 365

FEBRUARY 28, 2021

COLLABORATION WILL LEVERAGE THE NURTURE PATIENT BIOBANK AND EVOTEC’S MULTI-OMICS PLATFORMS PANHUNTER AND PANOMICS EVOTEC AND CHINOOK AIM TO … Continue reading → DGAP-News: Evotec SE / Key word(s): Miscellaneous 01.03.2021 / 07:30 The issuer is solely responsible for the content of this announcement.

Biobanking 40

Biobanking Medicine Development 40

JAMA Internal Medicine

JULY 18, 2021

This cohort study assesses the association between consumption of common caffeinated products and the risk of arrhythmias using data from the UK Biobank.

Biobanking 76

Biobanking Production 76

Scienmag

JANUARY 26, 2021

The COVID-19 Neuro Databank/Biobank (NeuroCOVID), which was created and will be maintained by NYU Langone Health, New York City, will be a resource of clinical information as well as biospecimens from […].

Biobanking 72

Biobanking Engineer Medicine 72

pharmaphorum

JANUARY 18, 2023

The idea of ‘genetic superheroes’ and precision medicine is captivating for researchers, but the concept can be abstract and distant for participants. In our experience of running 20+ precision medicine studies, there are a few design principles that every research programme – from biobanks to clinical trials – should consider.

Genetic Disease 88

Genetic Disease Genetics Research Genome 88

Drug Discovery World

NOVEMBER 7, 2022

Genomic healthcare data is critical to identify disease risk, ancestry, traits and response to medicines and aids in the development of new targeted therapies – precision medicines. DDW’s Megan Thomas observes developments of accessibility in this sector and the potential impact. . The origins . The current landscape .

Genome 98

Genome Genomics Development Genetics 98

Scienmag

DECEMBER 15, 2020

An Academy of Finland Academy Programme, Health from Cohorts and Biobanks (COHORT), has become a global forerunner in the collaborative use of existing research data. Over the past two decades, Finnish research on health promotion has reached a very high level in global terms.

Biobanking 58

Biobanking Research Medicine 58

pharmaphorum

JANUARY 3, 2023

After passing on the reins of NICE, he was appointed chair of the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), heading up the agency for two 3-year terms between 2014 and 2020. Dillon said in a statement that Rawlins was “an inspirational leader and always loyal and supportive to those around him. .”

Biobanking 52

Biobanking Medicine Drugs Production 52

Drug Discovery World

OCTOBER 26, 2022

A study by the Qatar Genome Research Consortium, led by Dr Lotfi Chouchane from Weill Cornell Medicine-Qatar, has reported the first landscape of cancer germline mutations – hereditary mutations – in the Qatari population. . These variants increase the risk of developing breast cancer in women and prostate cancer in men. .

Genome 52

Genome Genomics Biobanking Genetics 52

pharmaphorum

DECEMBER 2, 2021

GlaxoSmithKline has formed a five-year partnership with Oxford University to set up a new institute that will apply machine learning and functional genomics to the discovery of new medicines. ” The post GSK pumps £30m into a new Oxford University partnership appeared first on.

Biobanking 76

Biobanking Genome Genomics Genetics 76

Scienmag

JUNE 8, 2021

The research, which relied on data from the UK Biobank, the Early Growth Genetics consortium, and the Genetic Factors for Osteoporosis consortium, also found […].

Biobanking 44

Biobanking Genetics Research Medicine 44

Drug Discovery World

APRIL 4, 2024

To date, the samples for the Biobank have been genotyped using microarray-based methods. The post Estonia National Biobank to sequence 10,000 whole genomes appeared first on Drug Discovery World (DDW).

Biobanking 52

Biobanking Genome Genomics Genome Project 52

JAMA Internal Medicine

JULY 31, 2018

This population-based study of UK Biobank data assesses the association between coffee intake and mortality according to genetic caffeine metabolism scores.

Genetics 40

Genetics Biobanking 40

pharmaphorum

JANUARY 24, 2023

As part of the US government’s Cancer Moonshot initiative, a Cancer Moonshot Biobank was launched that asked participants to donate biospecimens and associated health information to aid research. Certain genetic variants influence the way the body responds to specific medicine.

Genetics 92

Genetics Drugs Genome Project Biobanking 92

pharmaphorum

NOVEMBER 24, 2022

More than two years on, the EU medicines regulator has now selected the first set of data partners to collaborate with DARWIN EU, which focuses on real-world evidence collected on a patient’s health status or delivery of healthcare from a variety of sources, other than conventional clinical trials.

Big Data 52

Big Data Biobanking Regulation Medicine 52

pharmaphorum

MARCH 19, 2021

As data and digital technology become vital to every aspect of life sciences, the industry is increasingly looking beyond biologists, chemists, and doctors to drive its drug development – and finding that technology has a chief role to play in the future of medicine. According to an article by Stephens, Zachary D.,

Bioinformatics 59

Bioinformatics Drugs Genome Genomics 59

The Pharma Data

JANUARY 14, 2021

from the Yale School of Medicine in New Haven, Connecticut, and colleagues conducted a one-sample Mendelian randomization (MR) study using data for participants of European descent from the U.K. Biobank that enrolled more than 500,000 Britons aged 40 to 69 years from 2006 to 2010. THURSDAY, Jan. 14 in Stroke. Acosta, M.D.,

Genetics 52

Genetics Biobanking Medicine Research 52

pharmaphorum

JULY 5, 2022

Notable highlights include the central role the UK has played in the field of genomics, with over 500 thousand patients now in the biobank, and the recent RECOVERY trial – the world’s largest clinical trial into treatments for Covid-19, with more than 40,000 participants across 185 trial sites in the UK. Accelerating access for patients.

Life Science 98

Life Science Biobanking Medicine Marketing 98

pharmaphorum

JANUARY 26, 2023

A 2022 study from the Royal College of Physicians and British Pharmacological Society demonstrated the potential of pharmacogenomics, with scientists identifying the genetic cause behind an individual’s drug response for over forty medicines.

Genome 124

Genome Genomics Genome Project Genetics 124

The Pharma Data

JULY 12, 2021

online issue of Nature Communications, researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval. “Academic labs and pharmaceutical and? the success rates in drug discovery?are

Drugs 52

Drugs Gene Expression Big Data Gene 52

Drug Discovery World

FEBRUARY 27, 2024

From these data, we can discover new medicines with a higher probability for success. In oncology and other areas of medicine, significant progress has been made by advances in genomics to better define patient biology to enable targeted precision therapeutics. Is AI / machine learning (ML) the best way to utilise this data at scale?

Genome 52

Genome Genomics Genotype Medicine 52

Crucial Data Soutions

JUNE 28, 2021

Step 2: escalating to jumping on the phone to talk live with the central lab, the bioanalytical lab, the sites, the biobank or anyone else in a quest to hunt down a specific sample. The increased focus on digitization in clinical trials is key to the future of precision medicine and personalized care.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Biobanking 52

Delveinsight

MARCH 2, 2021

Evotec and Chinook Therapeutics have collaborated to develop and discover precision medicine therapies for patients with chronic kidney diseases (CKD). The duo plans to jointly identify, characterize and validate novel mechanisms and discover and develop precision medicines.

Drug Delivery 40

Drug Delivery Research Drugs Gene Editing 40

Roots Analysis

DECEMBER 8, 2021

The advancements and research in the field of cellular therapies, regenerative medicine, biobanking and drug discovery have led to the demand for biopreservation media in the pharmaceutical, biotechnology and healthcare sector. The figure below portrays the various sectors / segments where media can be employed.

Packaging 52

Packaging Packaging In-Vivo Biobanking 52

Drug Discovery World

APRIL 20, 2023

Structural MRI data from the UK Biobank cohort found reductions in global brain size, particularly reduced grey matter thickness in the orbitofrontal cortex and parahippocampal gyrus, among participants who had had Covid-19, an average of 141 days before scanning 11. link] (accessed Nov. Elsevier Inc., 1277–1279, Nov. doi: 10.1016/j.amjmed.2022.07.017.

Development 98

Development Drugs Clinical Trials Clinical Trials 98

XTalks

FEBRUARY 4, 2021

The power of leveraging clinical data to decipher disease mechanisms and fuel drug discovery has rapidly grown in the era of genomics and personalized medicine. Biobanks are used for the coordination of high-yield patient sample collection. Generation of strong research dataset cohorts must begin with high-quality clinical samples.

Research 98

Research Biobanking Drugs Genome 98

The Pharma Data

DECEMBER 9, 2020

5 and attracted participants from around the world, including radiologists, radiation oncologists, physicists in medicine, radiologic technologists, and other health care professionals. Biobank and a clinical practice dataset of images collected at the University of Florida Center for Movement Disorders. 29 to Dec.

Radiology 52

Radiology Biobanking Genotype Medicine 52

The Pharma Data

JULY 15, 2021

Managed by the Broad Institute of MIT and Harvard, the browser gives access to results from analyses of whole exome sequencing data from 300,000 UK Biobank research participants. AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow.

Biobanking 52

Biobanking Genetics Protein Medicine 52

The Pharma Data

JULY 8, 2021

Managed by the Broad Institute of MIT and Harvard, the browser gives access to results from analyses of whole exome sequencing data from 300,000 UK Biobank research participants. AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow.

Genetics 52

Genetics Biobanking Protein Containment 52

The Pharma Data

APRIL 11, 2023

The company has the passion and determination to develop innovative medicines that help improve and extend the lives of people living with cancer. The oncology franchise at Bayer includes six marketed products across various indications and several compounds in different stages of clinical development.

Research 40

Research Clinical Trials Clinical Trials Trials 40

The Pharma Data

JANUARY 31, 2021

s Medicines Discovery Catapult (MDC) stepped up to the plate to collate much-needed research resources when the pandemic broke out, and are continuing to pivot to ensure medical researchers have the resources they need to tackle both COVID-19 and the other diseases that refuse to step aside for it. . “You These are banks.

Research 52

Research Biobanking Clinical Trials Clinical Trials 52

Drug Discovery World

OCTOBER 30, 2023

We previously conducted a hypothesis-free study using genotype data from the UK Biobank, which resulted in the first mechanism-based stratification of endometriosis patients. RA: How will this data improve the chances of finding novel precision medicines for endometriosis?

Genome 72

Genome Genomics Genotype Clinical Trials 72